Reversing ABCC2-Mediated Oxaliplatin Resistance in Human PANC-1 Cells Using the CRISPR_cas9 System
Pancreatic ductal adenocarcinoma (PDAC) is considered to be a highly aggressive malignancy that often shows minimal symptoms, early signs of the disease are difficult and often impossible to identify until the later stages of the disease due to the location of the pancreas. Oxaliplatin is a critical...
Main Author: | Cullen, Camren (Author) |
---|---|
Other Authors: | Li, Yan (Contributor) |
Format: | Others |
Published: |
Auckland University of Technology,
2021-09-16T02:19:02Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Targeting MRP2 in HepG2 Cells Using the CRISPR-Cas9 System to Reverse Oxaliplatin Resistance
by: Zou, Ying
Published: (2019) -
Modulation of ABCC2-Mediated Oxaliplatin Resistance in Colorectal Cancer Caco-2 Cell Line
by: Roy, Rhea
Published: (2021) -
Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
by: Bugde, Piyush
Published: (2019) -
Effective CRISPR/Cas9-based nucleotide editing in zebrafish to model human genetic cardiovascular disorders
by: Federico Tessadori, et al.
Published: (2018-10-01) -
CRISPR/Cas9-Mediated Three Nucleotide Insertion Corrects a Deletion Mutation in MRP1/ABCC1 and Restores Its Proper Folding and Function
by: Qinqin Xu, et al.
Published: (2017-06-01)